Article
Soluble LIGHT (TNFSF14) activates endothelial cells, thereby priming the first…
bioRxiv · 2023 · Philippe Chadebech
Key facts
| Title | Soluble LIGHT (TNFSF14) activates endothelial cells, thereby priming the first vessel-occlusive events in acute sickle cell disease |
|---|---|
| First author | Philippe Chadebech |
| Journal | bioRxiv |
| Published | Jun 8, 2023 |
| DOI | 10.1101/2023.06.08.541088 |
| Devices mentioned | DEN000008, K022086, K073506, K083846, K121399, K121894, K140377, K800552, K853723, K860811, K862004, K874160 and 17 more |
| Product codes mentioned | EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, NDS, NSU and 6 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1